CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale Chief Development Officer sold 1,527 shares at an average $1.57 ($2,396)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Director acquired 145,833 shares (option exercise)
- 4 Option exercise Director acquired 145,833 shares (option exercise)
- 4 Option exercise Director acquired 150,711 shares (option exercise)
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Development Officer sold 1,852 shares at $1.80 ($3,332)
Page 17 of 31 · 602 filings